1. Eris Lifesciences
stock logo

90% Buy

Eris Lifesciences Share Price

ERIS

₹1,043.95+₹7.10 (0.68%) TodayLast updated on 12 Jul, 2024 | 03:29 PM IST
₹1,029.50₹1,073.85
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹14,100 Crs

Open

₹1,036.85

Close

₹1,036.85

Circuit range

₹1,244.20 - ₹829.50

Day range

₹1,029.50 - ₹1,073.85

Year range

₹693.00 - ₹1,090.00

Volume

70,253

Avg. traded

₹1,048.95

Revenue (12m)

₹2,009 Crs

Eris LifesciencesEris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.

Eris Lifesciences Key indicators

arrow

52 week high

₹1,090.00

52 week low

₹693.00

P/E ratio

36.03

P/B ratio

5.43

ROE

19.25%

ROCE

20.54%

Dividend yield

0.71%

Debt/Equity ratio

0.14

EPS

29.27

Learn more

Investment checklist: (4/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

90%

Hold

10%

Sell

0%

This analysis is based on the reviews of 10 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

38.1%

Net profit margin

29.02%

ROE

19.25%

ROA

17.36%

ROCE

20.54%

Learn more

Eris Lifesciences Shareholder returns

arrow

1 day

+0.23%

1 week

-0.68%

1 month

+2.00%

3 months

+22.48%

1 year

+44.86%

3 years

+39.38%

5 years

+110.63%

Eris Lifesciences Share Price history

arrow
DayOpenCloseDay’s change
Thu, Jul 11 2024
₹1,041.40
₹1,036.85
+0.06%
Wed, Jul 10 2024
₹1,038.95
₹1,036.20
+0.23%
Tue, Jul 9 2024
₹1,034.30
₹1,033.80
+0.33%
Mon, Jul 8 2024
₹1,016.90
₹1,030.40
+1.82%
Fri, Jul 5 2024
₹1,034.00
₹1,011.95
-1.77%
Thu, Jul 4 2024
₹1,044.05
₹1,030.15
-1.26%
Wed, Jul 3 2024
₹1,032.30
₹1,043.25
+0.30%
Tue, Jul 2 2024
₹1,050.15
₹1,040.10
-0.96%

Shareholding info

arrow

Promoters (54.88%)

Mutual Funds (14.52%)

Retail and other (14.3%)

Foreign institutions-FII (14.59%)

Other domestic institutions (1.71%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹7.35/share

    Ex date 11 Aug 2022

    expand tab

Learn more

Frequently asked questions